Search results
Results From The WOW.Com Content Network
Fresenius SE & Co. KGaA is a German multinational health care company based in Bad Homburg vor der Höhe. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. [3] The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Vifor Fresenius Medical Care Renal Pharma (VFMCRP), the joint company with Fresenius Medical Care since 2010, gives CSL Vifor access to a network of dialysis centers. [23] It is active in the treatment of chronic kidney disease (CKD), [ 31 ] chronic kidney disease-associated pruritus , [ 32 ] renal anemia [ 33 ] and hyperphosphatemia .
Find us on X (formerly known as Twitter) or Facebook. Paid members In addition to the support options listed above, paid members also have access to 24/7 phone support by calling 1-800-827-6364.
The Department of Justice of the U.S. government files a civil complaint against Fresenius (FMS), accusing it of defrauding Medicare and other healthcare programs by billing for unnecessary ...
The investigation, which began earlier in the year and is in the early stages, focuses partly on how difficult the two companies that dominate the U.S. dialysis market have made it for physicians ...
B. Braun is a German medical and pharmaceutical device company, which currently has more than 63,000 employees globally, and offices and production facilities in more than 60 countries. Its headquarters are located in Melsungen, in central Germany. The company was founded in 1839 and is still owned by the Braun family. [2]
LifeScan was established in 1981. [3] It was acquired by Johnson & Johnson (J&J) in 1986, [2] [4] and in June 2018, J&J agreed to sell LifeScan to Platinum Equity as part of its strategic exit from the diabetes device market, accepting an offer originally tendered in March 2018. [1]